Related Experiment Video

Updated: May 1, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

14.6K

Success stories about severe pneumonia caused by Panton-Valentine leucocidin-producing Staphylococcus aureus

Paramythiotou Elisabeth1, Souli Maria2, Galani Irene2

  • 12nd University Department of Critical Care, Attikon University Hospital, Athens, Greece.

The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|April 3, 2014
PubMed

Insights

Community-acquired necrotizing pneumonia caused by Panton-Valentine leucocidin-producing Staphylococcus aureus can be fatal. Prompt antimicrobial therapy and high clinical suspicion are crucial for successful patient outcomes without sequelae.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pulmonology

Background:

  • Necrotizing pneumonia is a severe lung infection with high morbidity and mortality.
  • Staphylococcus aureus, particularly strains producing Panton-Valentine leucocidin (PVL), is an emerging cause of severe pneumonia.

Observation:

  • Three cases of community-acquired necrotizing pneumonia are presented.
  • All cases were caused by PVL-producing Staphylococcus aureus strains.
  • One case involved a methicillin-sensitive Staphylococcus aureus (MSSA) strain.

Findings:

  • All three patients received prompt and adequate antimicrobial therapy.
  • All patients were successfully treated without any long-term complications or sequelae.
  • Early recognition and appropriate treatment were key to favorable outcomes.

Implications:

  • Highlights the importance of considering PVL-producing Staphylococcus aureus in severe pneumonia cases.
  • Emphasizes the critical role of timely and appropriate antimicrobial treatment in managing this potentially fatal infection.
  • Suggests that high clinical suspicion can lead to early diagnosis and intervention, improving patient prognosis.
Keywords:
ClindamycinCommunity-acquired pneumoniaPanton–Valentine leukocidinStaphylococcus aureus

More Related Videos

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

8.6K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

17.4K

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.2K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.2K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K